Clostridium difficile Toxins

Bacterial Toxins: Tools in Cell Biology and Pharmacology

Volumn , Issue , 2008, Pages 141-158

  Thelestam, M ^a   Florin, I ^a   Chaves Olarte, E ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Anti actin antibodies; Clostridium difficile; Hemorrhagic fluid; Homogeneity; Pseudomembranous

Indexed keywords

EID: 84954214925     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9783527614615.ch12     Document Type: Chapter

References (107)

1. Ahlgren T, Florin I, Jarstrand C, et al. (1983): Loss of surface fibronectin from human lung fibroblasts exposed to cytotoxin from Clostridium difficile. In Infect. Immun. 39: 1470-1472.
2. Aktories K, Barman M, Ohishi I, et al. (1986): Botulinum C2 toxin ADP-ribosylates actin. In Nature (London) 322: 390-392.
3. Aktories K, Weller U, Chatwal GS (1987): Clostridium botulinum type C produces a novel ADP-ribosyltransferase distinct from C2 toxin. In FEBS Lett. 212: 109-113.
4. Aktories K, Just I (1995): Monoglucosylation of low-molecular-mass GTP-binding Rho proteins by clostridial cytotoxins. In Trends Cell Biol. 5: 441-443.
5. Arnon SS, Mills DC, Day PA, et al. (1984): Rapid death of infant rhesus monkeys injected with Clostridium difficile toxins A and B: Physiologic and pathologic basis. In J. Pediatr. 104: 34-40.
6. Banno Y, Kobayashi T, Watanabe K, et al. (1981): Two toxins (D-1 and D-2) of Clostridium difficile causing antibiotic-associated colitis: purification and some characterization. In Biochem. Int. 2: 629-635.
7. Banno Y, Kobayashi T, Kono H, et al. (1984): Biochemical characterization and biologic actions of two toxins (D-1 and D-2) from Clostridium difficile. In Rev. Infect. Dis. 6: S11-S20.
8. Barroso LA, Wang SZ, Phelps CJ, et al. (1990): Nucleotide sequence of the Clostridium difficile toxin B gene. In Nucl. Acids Res. 18: 4004.
9. Barroso LA, Moncrief JS, Lyerly DM, et al. (1994): Mutagenesis of the Clostridium difficile toxin B gene and effect on cytotoxic activity. In Microb. Pathogen. 16: 297-303.
10. Bartlett JG, Onderdonk AB, Cisneros RL, et al. (1977): Clindamycin-associated colitis due to a toxin-producing species of Clostridium in hamsters. In J. Inf. Dis. 136: 701-705.
11. Bartlett JG (1990): Clostridium difficile: Clinical considerations. In Rev. Inf. Dis. 12: S243-S251.
12. Ben-Ze'ev A, Farmer SR, Penman S (1980): Protein synthesis requires cell-surface contact while nuclear events respond to cell shape in anchorage-dependent fibroblasts. In Cell, 21: 365-372.
13. Bette P, Frevert J, Mauler F, et al. (1989): Pharmacological and biochemical, studies of cytotoxicity of Clostridium novyi type A alpha-toxin. In Infect. Immun. 57: 2507-2513.
14. Bette P, Oksche A, Mauler F, et al. (1991): A comparative biochemical, pharmacological and immunological study of Clostridium novyi alpha-toxin, C.difficile toxin B and C.sordellii lethal toxin. In Toxicon, 29: 877-887.
15. Bongaerts GPA, Lyerly DM (1994): Mini-review Role of toxins A and B in the pathogenesis of Clostridium difficile disease. In Microb. Pathogen. 17: 1-12.
16. Caspar M, Florin I, Thelestam M (1987): Calcium and calmodulin in cellular intoxication with Clostridium difficile toxin B. In J. Cell. Physiol. 132: 168-172.
17. Castagliuolo I, LaMont JT, Letourneau R, et al. (1994): Neuronal involvement in the intestinal effects of Clostridium difficile toxin A and Vibrio cholerae enterotoxin in rat ileum. In Gastroenterol. 107: 657-665.
18. Chang T-W Bartlett JG, Gorbach SL, et al. (1978): Clindamycin-induced enterocolitis in hamsters as a model of pseudomembranous colitis in patients. In Infect. Immun. 20: 526-529.
19. Chardin P, Boquet P, Madaule P, et al. (1989): The mammalian G-protein rhoC is ADP-ribosylated by Clostridium botulinum exoenzyme C3 and affects microfilaments in Vero cells. In EMBO J. 8: 1087-1092.
20. Chaves Olarte E, Florin I, Boquet P, et al. (1996): UDP-glucose deficiency in a mutant cell line protects against glucosyltransferase toxins from Clostridium difficile and Clostridium sordellii 271: 6925-6932.
21. Ciesielski-Treska J, Ulrich G, Baldacini O, et al. (1991): Phosphorylation of cellular proteins in response to treatment with Clostridium difficile toxin B and Clostridium sordellii toxin L. In Eur. J. Cell Biol. 56: 68-78.
22. Coso OA, Chiariello M, Yu J-C, et al. (1995): The small GTP-binding proteins Rac1 and Cdc42 regulate the activity of the JNK/SAPK signaling pathway. In Cell, 81: 1137-1146.
23. Dove CH, Wang SZ, Price SB, et al. (1990): Molecular characterization of the Clostridium difficile toxin A gene. In Infect. Immun. 58: 480-488.
24. Däubener W, Leiser E, von Eichel-Streiber Cv, et al. (1988): Clostridium difficile toxins A and B inhibit human immune response in vitro. In Infect. Immun. 56: 1107-1112.
25. Eichel-Streiber Cv, Sauerborn M (1990): Clostridium difficile toxin A carries a C-terminal repetitive structure homologous to the carbohydrate binding region of streptococcal glycosyltransferases. In Gene, 96: 107-113.
26. Eichel-Streiber Cv, Laufenberg-Feldmann R, Sartingen S, et al. (1990): Cloning of Clostridium difficile toxin B gene and demonstration of high N-terminal homology between toxin A and B. In Med. Microbiol. Immunol. 179: 271-279.
27. Eichel-Streiber Cv, Laufenberg-Feldmann R, Sartingen S, et al. (1992): Comparative sequence analysis of the Clostridium difficile toxins A and B. In Mol Gen Genet, 233: 260-268.
28. Eichel-Streiber Cv (1993): Molecular biology of the Clostridium difficile toxins. In Genetics and Molecular Biology of Anaerobic Bacteria (Sebald M, ed) pp 264-289, New York: Springer Verlag.
29. Eichel-Streiber CV, Meyer zu Heringdorf D, Habermann E, et al. (1995): Closing in on the toxic domain through analysis of a variant Clostridium difficile cytotoxin B. In Molec. Microbiol. 17: 313-321.
30. Fiorentini C, Arancia G, Paradisi S, et al. (1989): Effects of Clostridium difficile toxins A and B on cytoskeleton organization in Hep-2 cells: A comparative morphological study. In Toxicon, 27: 1209-1218.
31. Fiorentini C, Malorni W, Paradisi S, et al. (1990): Interaction of Clostridium difficile toxin A with cultured cells: cytoskeletal changes and nuclear polarization. In Infect. Immun. 58: 2329-2336.
32. Fiorentini C, Thelestam M (1991): Review article Clostridium difficile toxin A and its effects on cells. In Toxicon, 29: 543-567.
33. Fiorentini C, Chow SC, Mastrantonio P, et al. (1992): Clostridium difficile toxin A induces multinucleation in the human leukemic T cell line JURKAT. In Eur. J. Cell Biol. 57: 292-297.
34. Fiorentini C, Donelli G, Nicotera P, et al. (1993): Clostridium difficile toxin A elicits Ca2+ -independent cytotoxic effects in cultured normal rat intestinal crypt cells. In Infect. Immun. 61: 3988-3993.
35. Flegel WA, Müller F, Däubener W, et al. (1991): Cytokine response by human monocytes to Clostridium difficile toxin A and toxin B. In Infect. Immun. 59: 3659-3666.
36. Florin I, Thelestam M (1981): Intoxication of cultured human lung fibroblasts with Clostridium difficile toxin. In Infect. Immun. 33: 67-74.
37. Florin I, Thelestam M (1983): Internalization of Clostridium difficile cytotoxin into cultured human lung fibroblasts. In Biochim. Biophys. Acta, 763: 383-392.
38. Florin I, Thelestam M (1986): Lysosomal involvement in cellular intoxication with Clostridium difficile toxin B. In Microb. Pathogen. 1: 373-385.
39. Florin I (1991): Isolation of a fibroblast mutant resistant to Clostridium difficile toxins A and B. In Microb. Pathogen. 11: 337-346.
40. Florin I, Thelestam M (1991): ADP-ribosylation in Clostridium difficile toxin-treated cells is not related to cytopathogenicity of toxin B. In Biochim. Biophys. Acta, 1091: 51-54.
41. Frey SM, Wilkins TD (1992): Localization of two epitopes recognized by monoclonal antibody PCG-4 on Clostridium difficile toxin A. In Infect. Immun. 60: 2488-2492.
42. Gilbert RJ, Triadafilopoulos G, Pothoulakis C, et al. (1989a): Effect of purified Clostridium difficile toxins on intestinal smooth muscle. I. Toxin A. In Am. J. Physiol. 256: G759-G766.
43. Gilbert RJ, Pothoulakis C, LaMont JT (1989b): Effect of purified Clostridium difficile toxins on intestinal smooth muscle. II. Toxin B. In Am. J. Physiol. 256: G767-G772.
44. Gilbert RJ, Pothoulakis C, LaMont JT, et al. (1995): Clostridium difficile toxin B activates calcium influx required for actin disassembly during cytotoxicity. In Am. J. Physiol. 268: G487-G495.
45. Giry M, Popoff MR, Eichel-Streiber Cv, et al. (1995): Transient expression of RhoA, -B, and -C GTPases in HeLa cells potentiates resistance to Clostridium difficile toxins A and B but not to Clostridium sordellii lethal toxin. In Infect Immun. 63: 4063-4071.
46. Green GA, Schué V, Monteil H (1995): Cloning and characterization of the cytotoxin L-encoding gene of Clostridium sordellii: homology with Clostridium difficile cytotoxin B. In Gene, 161: 57-61.
47. Hall JC, O'Toole E (1935): Intestinal flora in new-born infants with a description of a new pathogenic anaerobe Bacillus difficilis. In Am J. Dis. Child. 49: 390-402.
48. Hecht G, Pothoulakis C, LaMont JT, et al. (1988): Clostridium difficile toxin A perturbs cytoskeletal structure and tight juncion permeability of cultured human intestinal epithelial monolayers. In J. Clin. Invest. 82: 1516-1524.
49. Hecht G, Koutsouris A, Pothoulakis C, et al. (1992): Clostridium difficile toxin B disrupts the barrier function of T84 monolayers. In Gastroenterology, 102: 416-423.
50. Henriques B, Florin I, Thelestam M (1987): Cellular internalization of Clostridium difficile toxin A. In Microb. Pathogen. 2: 455-463.
51. Hofmann F, Herrmann A, Habermann E, et al. (1995): Sequencing and analysis of the gene encoding the alpha-toxin of Clostridium novyi proves its homology to toxins A and B of Clostridium difficile. In Mol Gen Genet, 247: 670-679.
52. Just I, Fritz G, Aktories K, et al. (1994a): Clostridium difficile toxin B acts on the GTP-binding protein Rho. In J. Biol. Chem. 269: 10706-10712.
53. Just I, Richter H-P, Prepens U, et al. (1994b): Probing the action of Clostridium difficile toxin B in Xenopus laevis oocytes. In J. Cell Sci. 107: 1653-1659.
54. Just I, Selzer J, Eichel-Streiber Cv, et al. (1995a): The low molecular mass GTP-binding protein Rho is affected by toxin A from Clostridium difficile. In J. Clin. Invest. 95: 1026-1031.
55. Just I, Selzer J, Wilm M, et al. (1995b): Glucosylation of Rho proteins by Clostridium difficile toxin B. In Nature, 375: 500-503.
56. Just I, Wilm M, Selzer J, et al. (1995c): The enterotoxin from Clostridium difficile (ToxA) monoglucosylates the Rho proteins. In J. Biol. Chem. 270: 13932-13936.
57. Kamiya S, Reed PJ, Borriello SP (1989): Purification and characterisation of Clostridium difficile toxin A by bovine thyroglobulin affinity chromatography and dissociation in denaturing conditions with or without reduction. In J. Med. Microbiol. 30: 69-77.
58. Karlsson K-A (1995): Microbial recognition of target-cell glycoconjugates. In Curr. Opin. Struct. Biol. 5: 622-635.
59. Kelly CP, Becker S, Linevsky JK, et al. (1994): Neutrophil recruitment in Clostridium difficile toxin A enteritis in the rabbit. In J. Clin. Invest. 93: 1257-1265.
60. Krivan HC, Clark GF, Smith DF, et al. (1986): Cell surface binding site for Clostridium difficile enterotoxin: Evidence for a glycoconjugate containing the sequence Galalpha1-3Galbeta1-4GlcNAc. In Infect. Immun. 53: 573-581.
61. Kurose I, Pothoulakis C, LaMont JT, et al. (1994): Clostridium difficile toxin A-induced microvascular dysfunction. Role of histamine, In J. Clin. Invest. 94: 1919-1926.
62. Kushnaryov VM, Sedmak JJ (1989): Effect of Clostridium difficile enterotoxin A on ultrastructure of Chinese hamster ovary cells. In Infect. Immun. 57: 3914-3921.
63. Kushnaryov VM, Redlich PN, Sedmak JJ, et al. (1992): Cytotoxicity of Clostridium difficile toxin A for human colonic and pancreatic carcinoma cell lines. In Cancer Res. 52: 5096-5099.
64. Larson HE, Parry JV, Price AB, et al. (1977): Undescribed toxin in pseudomembranous colitis. In Brit. Med. J. 1: 1246-1248.
65. Libby JM, Wilkins TD (1982): Production of antitoxins to two toxins of Clostridium difficile and immunological comparison of the toxins by cross-neutralization studies. In Infect. Immun. 35: 374-376.
66. Libby JM, Jortner BS, Wilkins TD (1982): Effects of the two toxins of Clostridium difficile in antibiotic-associated cecitis in hamsters. In Infect. Immun. 36: 822-829.
67. Lima AA, Lyerly DM, Wilkins TD, et al. (1988): Effects of Clostridium difficile toxins A and B in rabbit small and large intestine in vivo and on cultured cells in vitro. In Infect. Immun. 56: 582-588.
68. Lima AA, Innes DJ, Chadee K, et al. (1989): Clostridium difficile toxin A. Interaction with mucus and early sequential histopathologic effects in rabbit small intestine. In Lab. Invest. 61: 419-425.
69. Lyerly DM, Saum KE, MacDonald DK, et al. (1985): Effects of Clostridium difficile toxins given intragastrically to animals. In Infect. Immun. 47: 349-352.
70. Lyerly DM, Roberts MD, Phelps CJ, et al. (1986): Purification and properties of toxins A and B of Clostridium difficile. In FEMS Microbiol. Lett. 33: 31-35.
71. Lyerly DM, Krivan HC, Wilkins TD (1988): Clostridium difficile: its disease and toxins. In Clin. Microbiol. Rev. 1: 1-18.
72. Lyerly DM, Carrig PE, Wilkins TD (1989): Susceptibility of Clostridium difficile toxins A and B to trypsin and chymotrypsin. In Microb. Ecol. Health & Dis. 2: 219-221.
73. Lyerly DM, Wilkins TD (1995): Clostridium difficile. In Infections of the gastrointestinal tract (Blaser MJ, Smith PD, Ravdin JI, et al. eds) pp 867-891, New York: Raven Press, Ltd
74. Malorni W, Fiorentini C, Paradisi S, et al. (1990): Surface blebbing and cytoskeletal changes induced in vitro by toxin B from Clostridium difficile: An immunochemical and ultrastructural study. In Exp. Molec. Pathol. 52: 340-356.
75. Martinez RD, Wilkins TD (1992): Comparison of Clostridium sordellii toxins HT and LT with toxins A and B of C.difficile. In J. Med. Microbiol. 36: 30-36.
76. Meador III J, Tweten RK (1988): Purification and characterization of toxin B from Clostridium difficile. In Infect. Immun. 56: 1708-1714.
77. Moore R, Pothoulakis C, LaMont JT, et al. (1990): C.difficile toxin A increases intestinal permeability and induces CI- secretion. In Am. J. Physiol. 259: G165-G172.
78. Müller H, Eichel-Streiber Cv, Habermann E (1992): Morphological changes of cultured endothelial cells after microinjection of toxins that act on the cytoskeleton. In Infect. Immun. 60: 3007-3010.
79. Nishiyama T, Sasaki T, Takaishi K, et al. (1994): rac p21 is involved in insulin-induced membrane ruffling and rho p21 is involved in hepatocyte growth factor- and 12-O-tetradecanoylphorbol-13-acetate (TPA)-induced membrane ruffling in KB cells. In Mol. Cell. Biol. 14: 2447-2456.
80. Nusrat A, Giry M, Turner JR, et al. (1995): Rho protein regulates tight junctions and perijunctional actin organization in polarized epithelia. In Proc. Natl. Acad. Sci. 92: 10629-10633.
81. Olson MF, Ashworth A, Hall A (1995): An essential role for Rho, Rac, and Cdc42 GTPases in cell cycle progression through G1. In Science, 269: 1270-1272.
82. Ottlinger ME, Lin S (1988): Clostridium difficile toxin B induces reorganization of actin, vinculin, and talin in cultured cells. In Exptl Cell Res. 174: 215-229.
83. Popoff MR, Rubin EJ, Gill DM, et al. (1988): Actin-specific ADP-ribosyl-transferase produced by a Clostridium difficile strain. In Infect. Immun. 56, 2299-2306.
84. Popoff MR, Chaves-Olarte E, Lemichez E., et al. (1996): Ras, Rap, and Rac small GTP-binding proteins are targets for Clostridium sordellii lethal toxin glucosylation. In J. Biol. Chem. 271, 10217-10224.
85. Pothoulakis C, Sullivan R, Melnick DA, et al. (1988): Clostridium difficile toxin A stimulates intracellular calcium release and chemotactic response in human granulocytes. In J. Clin. Invest. 81: 1741-1745.
86. Pothoulakis C, Castagliuolo I, LaMont JT, et al. (1994): CP-96,345, a substance P antagonist, inhibits rat intestinal responses to Clostridium difficile toxin A but not cholera toxin. In Proc. Natl. Acad. Sci. 91: 947-951.
87. Price SB, Phelps CJ, Wilkins TD, et al. (1987): Cloning of the carbohydrate-binding portion of the toxin A gene of Clostridium difficile. In Curr. Microbiol. 16: 55-60.
88. Reuner KH, Presek P, Boschek CB, et al. (1987): Botulinum C2 toxin ADP-ribosylates actin and disorganizes the microfilament network in intact cells. In Eur. J. Cell Biol. 43: 134-140.
89. Ridley AJ, Hall A (1992): The small GTP-binding protein rho regulates the assembly of focal adhesion and actin stress fibers in response to growth factors. In Cell, 70: 389-399.
90. Ridley AJ, Paterson HF, Johnston CL, et al. (1992): The small GTP-binding protein rac regulates growth factor-induced membrane ruffling. In Cell, 70: 401-410.
91. Riegler M, Sedivy R, Pothoulakis C, et al. (1995): Clostridium difficile toxin B is more potent than toxin A in damaging human colonic epithelium in vitro. In J. Clin. Invest. 95: 2004-2011.
92. Rifkin GD, Fekety FR, Silva J, et al. (1977): Antibiotic-induced colitis implication of a toxin neutralised by Clostridium sordellii antitoxin. In Lancet, ii: 1103-1106.
93. Sauerborn M, Eichel-Streiber Cv (1990): Nucleotide sequence of Clostridium difficile toxin A. In Nucl. Acids Res. 18: 1629-1630.
94. Sauerborn M, Hegenbarth S, Laufenberg-Feldmann R, et al. (1994): Monoclonal antibodies discriminating between Clostridium difficile toxins A and B. In Bacterial protein toxins (Freer J, Aitken R, Alouf JE, et al. eds) pp 510-511, Stuttgart Jena New York: Gustav Fischer Verlag.
95. Schué V, Green GA, Girardot R, et al. (1994): Hyperphosphorylation of calnexin, a chaperone protein, induced by Clostridium difficile cytotoxin. In Biochem. Biophys. Res. Commun. 203: 22-28.
96. Self AJ, Paterson HF, Hall A (1993): Different structural organization of Ras and Rho effector domains. In Oncogene, 8: 655-661.
97. Shoshan MC, Åman P, Skog S, et al. (1990): Microfilament-disrupting Clostridium difficile toxin B causes multinucleation of transformed cells but does not block capping of membrane Ig. In Eur. J. Cell Biol. 53: 357-363.
98. Shoshan MC, Florin I, Thelestam M (1993a): Activation of cellular phospholipase A2 by Clostridium difficile toxin B. In J. Cell. Biochem. 52: 116-124.
99. Shoshan MC, Bergman T, Thelestam M, et al. (1993b): Dithiothreitol generates an activated 250,000 mol.wt form of Clostridium difficile toxin B. In Toxicon, 31: 845-852.
100. Siffert J-C, Baldacini O, Kuhry J-G, et al. (1993): Effects of Clostridium difficile toxin B on human monocytes and macrophages: possible relationship with cytoskeletal rearrangement. In Infect. Immun. 61: 1082-1090.
101. Sullivan NM, Pellet S, Wilkins TD (1982): Purification and characterization of toxins A and B of Clostridium difficile. In Infect. Immun. 35: 1032-1040.
102. Thelestam M, Brönnegård M (1980): Interaction of cytopathogenic toxin from Clostridium difficile with cells in tissue culture. In Scand. J. Infect. Dis. Suppl. 22: 16-29.
103. Thelestam M, Florin I (1984): Cytopathogenic action of Clostridium difficile toxins. In J. Toxicol. Toxin Rev. 3:139-180.
104. Thelestam M, Gross R (1990): Toxins acting on the cytoskeleton. In Handbook of toxinology (Shier WT, Mebs D, eds) pp 423-492, New York and Basel: Marcel Dekker, Inc.
105. Triadafilopoulos G, Pothoulakis C, Weiss R, et al. (1989): Comparative study of Clostridium difficile toxin A and cholera toxin in rabbit ileum. In Gastroenterol. 97: 1186-1192.
106. Tucker KD, Wilkins TD (1991): Toxin A of Clostridium difficile binds to the human carbohydrate antigens I, X, and Y. In Infect. Immun. 59: 73-78.
107. Wedel N, Toselli P, Pothoulakis C, et al. (1983): Ultrastructural effects of Clostridium difficile toxin B on smooth muscle cells and fibroblasts. In Exptl Cell Res. 148: 413-422.